BrightEdge

About The Fund

BrightEdge is the American Cancer Society’s mission-driven venture capital fund, focusing on patient-centric social innovation and mission-aligned impact investing. With a significant asset base of $5 billion under management, their primary goal is to combat cancer while advancing health equity across various communities. BrightEdge channels its investments toward for-profit companies that are developing novel cancer-focused treatments and technologies, bringing innovation to the market that can save lives and improve cancer care. The fund typically invests between $100,000 and $5,000,000, with a preferred investment 'sweet spot' of $1,500,000. Their specialty lies in seed and pre-seed stage financing for companies in multiple sectors including BioTech, FinTech & Financial services, HealthTech & Fitness, Medical Devices & Hospital Services, Healthcare & Wellness, Consumer, and Pharmaceuticals & Medicine. BrightEdge takes a strategic approach to investing, leveraging the American Cancer Society’s expertise to empower entrepreneurs and drive advances in cancer treatment, detection, and prevention. The fund also runs Project HEALTH, an accelerator program designed to amplify the impact of companies developing solutions to address healthcare disparities, reduce access barriers, and promote health equity. By investing in entrepreneurial early-stage companies, BrightEdge enables the commercialization of a broad spectrum of solutions aimed at tackling cancer from all angles. Their involvement extends beyond financial investment to include supporting companies as they navigate the challenges of bringing compelling solutions to the market, with a potential impact that could affect more than 3.5 million patients and families annually. Through strategic investment and commitment to fostering a world without cancer, BrightEdge supports the creation of a long-term, sustainable revenue stream for the ACS while offering investors and donors the opportunity to become part of a transformational journey in healthcare innovation and social change.